Research recommendation(s) from an individual piece of guidance
|Guidance:||Multiple myeloma - bortezomib|
|Date issued:||October 2007|
Research recommendations coming out of this guidance
- Further research into the effectiveness of bortezomib for the treatment of relapsed multiple myeloma is needed. Such studies should include...
- [NICE recommends] that further research should be carried out to establish the survival benefit in patients treated with bortezomib at first relapse whose [multiple...
This page was last updated: 14 November 2013